Weight gain before and after switch from TDF to TAF in a U.S. cohort study

INTRODUCTION: Although weight gain has been reported with the use of integrase strand transfer inhibitors (InSTI), concurrent use of tenofovir alafenamide (TAF) has been implicated in recent studies. This study examined weight changes in people living with HIV (PLWH) who switched from tenofovir diso...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Int AIDS Soc
Glavni autori: Mallon, Patrick WG, Brunet, Laurence, Hsu, Ricky K, Fusco, Jennifer S, Mounzer, Karam C, Prajapati, Girish, Beyer, Andrew P, Wohlfeiler, Michael B, Fusco, Gregory P
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2021
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8035674/
https://ncbi.nlm.nih.gov/pubmed/33838004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25702
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items